Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

2026 ACCP Annual Meeting

September 27 - 29, 2026 – Bethesda N Marriott Hotel & Conf Ctr N Bethesda, MD
Conference

CDISC US 2026

October 5 - 7, 2026
Conference

ISSX 27th North American Meeting

October 11 - 14, 2026 – San Francisco, CA

All regulatory resources

From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs

Certara Products - Certara IQ, Certara Products - Simcyp, Infectious Disease, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Oncology/Hematology, Publication

From Excel to Enterprise: A Sponsor’s Journey to Modern Clinical Metadata Management

Certara Products - Pinnacle 21, Data Standards, Webinar

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Certara Services, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

The five drug development questions that bring sponsors to pharmacometrics

Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Blog

Model-Based Meta-Analysis (MBMA): Real-World Examples

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - MBMA, Fact Sheet

A model-informed approach to radioligand therapy dosing under Project Optimus

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar

Go beyond basic validation: Achieve submission-ready datasets with Pinnacle 21 Enterprise

CDISC, Certara Products - Pinnacle 21, Fact Sheet

EANM 2026

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Webinar

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.